NEC is a devastating condition affecting premature infants. It involves necrosis of the intestinal tissue. Key factors that increase risk are prematurity, enteral feeding, and circulatory instability in the intestines. Clinically, infants may experience apnea, feeding intolerance, and abdominal distension. Diagnosis involves blood tests showing infection and inflammation as well as imaging showing abnormalities in the intestines. Treatment involves bowel rest, antibiotics, and sometimes surgery. Outcomes depend on severity but mortality can be over 40% in very premature infants and survivors face long-term complications.
Neonatal necrotizing enterocolitis
NEC is the most common life-threatening emergency of the gastrointestinal tract in the newborn period. The disease is characterized by various degrees of mucosal or transmural necrosis of the intestine. The cause of NEC remains unclear but is most likely multifactorial. The incidence of NEC is 1-5% of infants in neonatal intensive care units (NICUs). Both incidence and case fatality rates increase with decreasing birthweight and gestational age. Because very small, ill preterm infants are particularly susceptible to NEC, a rising incidence may reflect improved survival of this high-risk group of patients.
Clinical Manifestations
Infants with NEC have a variety of signs and symptoms and may have an insidious or sudden catastrophic onset (Table 96-1). The onset of NEC is usually in the 2nd or 3rd week of life but can be as late as 3 mo in VLBW infants. Age of onset is inversely related to gestational age. The 1st signs of impending disease may be nonspecific, including lethargy and temperature instability, or related to gastrointestinal pathology, such as abdominal distention and gastric retention. Obvious bloody stools are seen in 25% of patients. Because of nonspecific signs, sepsis may be suspected before NEC. The spectrum of illness is broad, ranging from mild disease with only guaiac-positive stools to severe illness with bowel perforation, peritonitis, systemic inflammatory response syndrome, shock, and death. Progression may be rapid, but it is unusual for the disease to progress from mild to severe after 72 hr.
Diagnosis
A very high index of suspicion in treating preterm at-risk infants is crucial. Plain abdominal radiographs are essential to make a diagnosis of NEC. The finding of pneumatosis intestinalis (air in the bowel wall) confirms the clinical suspicion of NEC and is diagnostic; 50-75% of patients have pneumatosis when treatment is started (Fig. 96-4). Portal venous gas is a sign of severe disease, and pneumoperitoneum indicates a perforation (Figs. 96-4 and 96-5). Hepatic ultrasonography may detect portal venous gas despite normal abdominal roentgenograms .
Neonatal necrotizing enterocolitis
NEC is the most common life-threatening emergency of the gastrointestinal tract in the newborn period. The disease is characterized by various degrees of mucosal or transmural necrosis of the intestine. The cause of NEC remains unclear but is most likely multifactorial. The incidence of NEC is 1-5% of infants in neonatal intensive care units (NICUs). Both incidence and case fatality rates increase with decreasing birthweight and gestational age. Because very small, ill preterm infants are particularly susceptible to NEC, a rising incidence may reflect improved survival of this high-risk group of patients.
Clinical Manifestations
Infants with NEC have a variety of signs and symptoms and may have an insidious or sudden catastrophic onset (Table 96-1). The onset of NEC is usually in the 2nd or 3rd week of life but can be as late as 3 mo in VLBW infants. Age of onset is inversely related to gestational age. The 1st signs of impending disease may be nonspecific, including lethargy and temperature instability, or related to gastrointestinal pathology, such as abdominal distention and gastric retention. Obvious bloody stools are seen in 25% of patients. Because of nonspecific signs, sepsis may be suspected before NEC. The spectrum of illness is broad, ranging from mild disease with only guaiac-positive stools to severe illness with bowel perforation, peritonitis, systemic inflammatory response syndrome, shock, and death. Progression may be rapid, but it is unusual for the disease to progress from mild to severe after 72 hr.
Diagnosis
A very high index of suspicion in treating preterm at-risk infants is crucial. Plain abdominal radiographs are essential to make a diagnosis of NEC. The finding of pneumatosis intestinalis (air in the bowel wall) confirms the clinical suspicion of NEC and is diagnostic; 50-75% of patients have pneumatosis when treatment is started (Fig. 96-4). Portal venous gas is a sign of severe disease, and pneumoperitoneum indicates a perforation (Figs. 96-4 and 96-5). Hepatic ultrasonography may detect portal venous gas despite normal abdominal roentgenograms .
Necrotizing enterocolitis (NEC) is a life-threatening emergency of the gastrointestinal tract in the newborn period.
The most common gastrointestinal condition in premature neonates.
It is characterized by inflammation, ischemia, and permeability of the neonatal bowel wall to bacteria.
It is potentially life-threatening with significant associated morbidity.
The disease is characterized by various degrees of mucosal or transmural necrosis of the intestine.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
2. • B/o Sabiya Banu,32 wks,1.7kg,admitted on 2HOL
with provisional diagnosis of MPT/LBW/Moderate
RDS.
• H/o PPROM>72 hours,no antenatal steroids.
• CPAP started at 2 HOL,recieved late rescue
surfactant at 4HOL ,INSURE .
• Removed from CPAP at 48 HOL.
• Initial septic screen was negative.
• Baby on 2nd line Ab as per protocol.
3. • Baby started with feeds 3ml/3hrly RTF of EBM on D3 of life.
• Feeds gradually increased twice daily
increment(30ml/kg/day)
• On D7 of life baby on 23ml RTF,developed abdominal
distension,residual feeds.AG-27cm.
• Abdomen –Soft,mild distension,non tender,Bowel sounds –
heard.No abdomen wall edema/erythema.
• Investigations-TLC-10,590/cumm,
Plt-12,000/cumm.CRP-62.5mg/dl. Serum Na-124mEq/dl.
• Stool occult blood-positive
• Diagnosis of NEC stage 1A was made .
• Baby kept NPO and Ab’s changed to Meropenem &
ofloxacin
• In view of broad spectrum Ab’s and other risk factors
Flucanozole was added.
4. • Surgical consultation –advised for medical line of
management.
• After 48hrs of bowel rest,Repeat invetsigations requested
showed-TLC-7870/cumm,PLT-40000/cumm and CRP of
94.1mg/L.
• In view of persistent distension and RTA baby was kept NPO
for 5days.
• Baby was restarted on feeds after 5 days of bowel
rest.(D=9)
• Baby started with 3ml RTF/3hrly and gradually increased
with once daily increment.
• After 3 days of feed on 10ml/EBM 3 hrly,baby had repeat
bout of feed intolerance.(D=12 )
• Repeat counts D12-Hb-11.3Gm%,TLC-10,720 and
platelet -35,000/cumm. CRP-53.2mg/L.
• USG abdomen D15-Minimal turbid ascites,small bowel
edema,no pneumobilia.
• Diagnosis was revised to NEC stage 2B.
5. • Baby kept NBM and continued with same
antibiotics.
• On D19 baby noticed to have significant
tachycardia 190bpm,bounding periphreal pulses
and PSM.Screening echo showed PDA 4mm with L
to R shunt.(RFT-WNL,Plt-75,000/cumm)
• Received Oral Ibubrofen for 3days.
• Baby restarted on feeds after 7 days of bowel rest
D21 of life RTF EBM 3ml/3hrly.
8. • Most common GI emergencies in the newborn
infant.
• Defined as:
Transmural coagulative necrosis of the
intestinal mucosa,with invasion of enteric gas
forming organisms, and dissection of gas into
the muscularis and portal venous system .
9. Epidemology:
• 1 -3 /1000 live births and 1 -7.7 % of admissions to
NICUs .
• Rates were inversely related to BW
401 to 750 g – 11.5%
751 to 1000 g – 9 %
1001 to 1250 g – 6 %
1251 to 1500 g – 4 %
• Mortality rates range from 15- 30% and are inversely
related to GA and BW.
• Approximately 13 % of cases occur in term,have a pre
existing illness- IUGR,congenital heart disease ,
respiratory distress , sepsis , birth asphyxia , and
polycythemia .
10. Pathology:
• The terminal ileum and colon are MC involved,
entire GI tract is affected in severe cases.
• On gross examination- the bowel distended and
hemorrhagic. Subserosal collections of
gas,gangrenous necrosis and perforation may be
present.
• Histologic findings in NEC -mucosal edema,
hemorrhage, and transmural coagulative
necrosis.
-secondary bacterial infiltration, and collections of
gas.
14. Prematurity:
• Immature mucosal barrier with increased
permeability
• Immature local host defenses.
• Immature bowel motility and function.
15. Enteral nutrition
• More than 90 percent of infants who develop NEC have
received milk feeding
• Incompletely digested carbohydrates and lipids in the
intestine of preterm infants cause mucosal injury .
• Human milk, protective :PAF acetylhydrolase, S IgA, IL-
10, IL-11, EGF , nucleotides, glutamine, and
antioxidants such as vit E, carotene, and glutathione.
16. Anemia & RBC transfusion:
• Multicenter observational’ cohort study
reported that severe anemia and not RBC
transfusion was associated with NEC.
• Clinically-significant anemia is associated with
an increased risk for NEC, and that RBC
transfusion is only a surrogate marker for
anemia
‘Patel RM, Knezevic A, Shenvi N, et al. Association of Red Blood Cell Transfusion, Anemia, and
Necrotizing Enterocolitis in Very Low-Birth-Weight Infants. JAMA 2016; 315:889
17. Medications
• Hyperosmolar medications and formulas can
cause mucosal injury and may result in NEC-
oral theophylline, multivitamins,
or phenobarbitone.
• Cimetidine, ranitidine, and famotidine, are
associated with higher rates of NEC.
• Antibiotic administration greater than five
days duration is associated with an increased
risk of NEC or death
18. Clinical Presentation:
• Majority of premature infants who develop
NEC are healthy, feeding well, and growing
babies.
• Onset of symptoms varies and is inversely
related to gestational age
GA< 26 weeks-23 days,
GA >31 weeks- 11 days.
• Indian data peak age –end of 1stwk to 2nd
week
20. Modified Bells staging for NEC:
• Bell staging criteria (Walsh & Kleigman)
provide a uniform definition of NEC based
upon the severity of systemic, intestinal, and
radiographic findings.
1. Stage I/suspected NEC
2. Stage II/proven NEC
3. Stage III/advanced NEC
22. Investigations:
Abdomen X ray
• Abnormal gas pattern with dilated loops of bowel -ileus, early stages
of NEC.
• Bowel wall edema
• Pneumatosis intestinalis, the hallmark of NEC, appears as bubbles of
gas in the small bowel wall, stages II and III NEC .
• Gasless abdomen indicating ascites.
• Pneumoperitoneum bowel perforation occurs , IIIB NEC.
-"football" sign on a supine radiograph,large hypolucent area in the
central abdomen with markings from the falciform ligament.
• Sentinel loops, a loop of bowel that remains in fixed position, is
suggestive of necrotic bowel and/or perforation in the absence of
pneumatosis intestinalis.
In EPT, treatment -clinical suspicion as confirmatory
radiographic findings may not be present
23.
24. USG abdomen:
• USG more sensitive method to detect
intramural air and portal venous gas .
• USG can detect intermittent gas bubbles in
liver parenchyma and the portal venous
system that are not detected by radiographs
• Color Doppler USG more sensitive than
abdominal radiography in detecting bowel
necrosis and alterations in bowel wall
perfusion
25. Blood and serum studies:
• WBC count <1500/cumm –poor prognostic factor
• Thrombocytopenia, persistent metabolic acidosis, and severe
refractory hyponatremia triad of signs and help to confirm the
diagnosis.
• Serial measurements of CRP - diagnosis and assessment of
response to therapy of severe NEC.
• Blood cultures are positive in ˜40% of cases
Analysis of stool:
• Grossly bloody stools may be an indication of NEC, routine
testing of stool for occult blood has no value .
• 60% of infants will have Hemoccult-positive stools at any
given time during hospitalization without any evidence for
NEC
26. D/D’s
1. Sepsis with Ileus
2. Infectious enteritis
3. Spontaneous intestinal perforation of the
newborn
4. Intestinal obstruction –enterocolitis in
Hirschsprung disease, ileal atresia, volvulus,
meconium ileus, and intussusception.
5. Anal fissures
6. Neonatal appendicitis
7. Cow's milk protein allergy
28. Supportive Care:
• Bowel rest with gastrointestinal decompression
with intermittent nasogastric suction.
• Total parenteral nutrition
• Fluid replacement to correct third space losses
• Support of both the cardiovascular( inotropes)
and respiratory systems (O2 & Ventilation as
needed).
• Correction of hematologic (DIC) and metabolic
abnormalities (metabolic acidosis).
29. Antibiotics:
• After obtaining appropriate specimens for
culture, broad spectrum antibiotic treatment
should be initiated for suspected or proven
NEC.
• Regimens should provide coverage for
pathogens that cause late-onset bacteremia.
• Anaerobic coverage considered-peritonitis or
pneumoperitoneum, suggesting intestinal
perforation.
30. • Lack of consensus, and the choice of
antibiotic regimen varies among NICU
1. Ampicillin, gentamicin ,and metronidazole
2. Ampicillin, gentamicin, and clindamycin
3. Ampicillin, cefotaxime, and metronidazole
4. Piperacillin.tazobactam and gentamicin
5. Vancomycin, piperacillin-tazobactam,
and gentamicin.
6. Meropenem
31. Surgical management:
Indications
• Perforation on abdominal X
ray(pneumoperitoneum)
• Positvie test on paracentesis(stool ,organism)
• Failure of medical management.
• Single fixed bowel loop on radiograph
• Abdominal wall erythema.
• Palpable mass
32. • Ideally surgery performed after intestinal necrosis
but before perfoartion and peritonitis develop.
• Surgical procedures- exploratory laparotomy with
resection of the affected intestinal region, or
primary peritoneal drainage (PPD).
• PPD may be the preferred initial surgical
procedure in extremely low birth weight (ELBW)
infants and unstable premature infants.
33. Complications:
Early:
• Infectious complications – Sepsis, meningitis,
peritonitis, and abscess formation
• Disseminated intravascular coagulation- intestinal or
extraintestinal bleeding
• Respiratory and cardiovascular complications –
Hypotension, shock, and respiratory failure
• Metabolic complications – Hypoglycemia and
metabolic acidosis
Late:
• Stricture formation(9-36%)
• Short bowel syndrome.(9% surgical operated cases)
34. Mortality:
71,808 premature infants who were born between January 2005 and
December 2006 -Vermont Oxford Network
Fitzgibbons SC, Ching Y, Yu D, et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J
Pediatr Surg 2009; 44:1072
BW 501 to 750 g – 42 %
BW 751 to 1000 g – 29 %
BW 1001 to 1250 g – 21 %
BW 1251 to 1500 g – 16 %
• Mortality rate is higher in infants with more severe disease requiring
surgical intervention(30.8 versus 6.8 percent).
• Radiographic evidence of portal venous air, an increase in feeding volume
that was greater than 20 mL/kg per day, and an increase in the
concentration of HMF within 48 hours of developing NEC .
• Hematocrit < 22 % ,I:T ratio > 0.5, and total lymphocyte count
below 4000/microlt
35. Long term outcome:
• Approximately one-half of survivors have no long-term sequel.
• 10% infants will have late gastrointestinal morbidity-
persistent loose stools or frequent bowel movements
• Infants with NEC were at increased risk for cerebral palsy, and
cognitive and severe visual impairment.
• Patients who were surgically treated had poorer
neurodevelopmental outcome than those treated medically.
• ELBW infants who required surgical care were more likely to
have significant growth delay and poorer developmental
outcome at 18 to 22 months.
Hintz SR, Kendrick DE, Stoll BJ, et al. Neurodevelopmental and growth outcomes of extremely low birth weight
infants after necrotizing enterocolitis. Pediatrics 2005; 115:696.
36. Prevention of NEC:
• Antenatal corticosteroids reduced the risk for NEC
approximately by half.
• Human milk compared with formula is the most important strategy
associated with a lower risk of NEC( 2.8 times risk in formula fed)
• TIMING AND ADVANCEMENT OF FEEDING
The optimal timing of initiation of minimal enteral (trophic) feeding
remains uncertain and its association with NEC is lacking.
Advancement of enteral feed volumes at daily increments of 30 to
40 mL/kg compared to lower volumes of 15 to 24 mL/kg did not
increase the risk of NEC or death in VLBW infants (BW <1500 g)
Morgan J, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very
low birth weight infants. Cochrane Database Syst Rev 2015; :CD001241
37. Prevention of NEC:
• Routine use of probiotic –not recomended, the lack of an established
regimen of optimal strain and dosing, and the absence of quality
control regulation to ensure consistency and safety of product.
• Oral immunoglobulins may reduce NEC by inhibiting the release of
proinflammatory cytokines ,meta analysis administration of oral IgG
or IgG/IgA combination did not reduce the incidence .
• Lactoferrin,Arginine,Glutamine ,HMO-proven to be beneficaial in
some studies but not routinely recommended.
38. Prevention of NEC:
• Avoidance of histamine 2 blockers:Immunity provided
by gastric acid may be important in preventing the
cascade of infectious and inflammatory events.
• Avoidance of prolonged empirical antibiotic use :use of
prolonged initial empiric antibiotic (≥5 days duration)
started in the first three days of life was associated
with an increased risk of NEC or death.
• Unproven as measures to prevent NEC:use of feeding
protocols, judicious advancement of feeding, avoidance
of hypertonic formulas and contrast agents, and
prompt treatment of polycythemia.